The in vitro response of mouse thymocytes to various mycoplasmas was evaluated. Cultures of thymus cells from BALB mice were prepared in Earle minimal essential medium with 10% fetal calf serum. After an initial drop in viability, cell populations stabilized at approximately 105 viable cells/ml for 3 to 5 days. Concentrations of 106 to 108 colony-forming units of toxic isolates of Mycoplasma fermentans per ml killed over 50% of these cells in a dose-dependent fashion. Four other mycoplasmas (M. pneumoniae, M. hominis, M. arthritidis, and a nontoxic strain of M. fermentans) did not induce cytotoxicity of mouse thymocytes. Toxic isolates of M. fermentans multiplied in the presence of thymus cells as they were being inactivated. However, nonviable membrane preparations of these mycoplasmas were also toxic, indicating that growth of the organisms is not a prerequisite for the toxic effect. The relevance of these findings for the isolation and identification of the membrane-associated toxic factor is discussed.
Lethal toxicity is an experimental disease induced in mice by high doses of Mycoplasma fermentans (4, 5) . Only recent isolates such as the K1O strain have toxigenic potential, and they can induce many of the same biological responses seen in endotoxic shock (4) . For example, the shock-type syndrome includes anorexia, prostration, mucosal exudates, and diarrhea. Histopathological responses include hepatocellular necrosis, "shock"-lung, and thymic involution. This latter reaction is especially dramatic since the tissue becomes necrotic with a nearly complete loss of architecture 24 h after mice receive lethal doses (approximately 3 x 101" colony-forming units [CFU] ) of M. fermentans K] . The thymus has been studied in some detail, but due to its key role in cellular immunity, most of the available data concern antigenicity and maturation of lymphoid tissue (8, 10, 11, (13) (14) (15) and not cellular responses to bacterial pathogens.
Because of the unusual sensitivity of the thymus to toxic isolates of M. fermentans, we designied the present study to define more precisely the in vivo and in vitro effects of mycoplasmas on thymus cells.
MATERIALS AND METHODS Mycoplasma. M. fermentans K10 was originally isolated from a bone marrow specimen obtained from a human leukemic patient (4) . M. fermentans PDMF 460 is a nontoxic (i.e., not lethal for mice, as is K10) laboratory strain obtained from Parke-Davis laboratories (4 Interaction of mycoplasmas and thymocytes in vitro. Two substrains of M. fermentans K10 were evaluated. One had been maintained in broth culture for at least 40 passages (K10-B), and the other had been passaged in BALB mice seven times by using thymus homogenates (K10-T). Both were cytotoxic. When used at levels of 106 to 10' CFU/ml, they reduced thymocyte viability to less than 50% of the untreated, control level. For example, K1O-T cells were grown in Murphy broth, collected by centrifugation, resuspended in MEM, and added to lymphocyte cultures when the cell population had stabilized (Fig. 2) . Cell concentrations of 2 x 108 CFU/ml of K1O-T reduced the lymphocyte titer from the control level of 1.3 x 105 to 3.3 x 10 within 24 h. A 10-fold dilution of K1O-T also caused a reduction in lymphocytes, but down to 6.8 x 10 viable cells/ml. Most of the cytotoxicity was noted in the first 24-h period, and the cell population tended to drop slowly (10 to 20% per day) after that time.
Similar dose response effects were noted with the standard K10-B strain ( a Approximately 108 CFU/ml.
anticipated 1-log drop in the controls. After 4 days in culture, the control cell counts were 1.5 x 105 viable cells/ml (initial titer, t = 0, was 2.0 x 106), whereas the K10-B-treated cells were at a titer of 3.0 x 104 viable cells/ml. The titer of mycoplasma cells was assayed simultaneously (Fig. 3) (7, 11) . Thymus-derived lymphocytes, or thymocytes, behave similarly and normally exhibit some deterioration in cell culture (7) and organ culture (9) . Thymocyte cultivation is also complicated by the fact that different cell types derived from the thymus normally mature and die at different rates in vitro (2, 10 It has been shown that antitumor compounds that inhibit deoxyribonucleic acid synthesis (e.g., actinomycin D, sparsomycin, and pactamycin) act synergistically with the K10 toxin in vivo (3, 4) . It would be desirable to also evaluate these compounds in vitro, using the thymocyte system described here. Given a pronounced increase in sensitivity, it is conceivable that cell cultures may serve as a bioassay to aid in the eventual isolation of the unique M. fermentans K10 toxin.
The precise mechanism that accounts for the thymocyte toxicity by K10 cells and membranes is not currently defined, though the present study does provide new information on the host-parasite interaction. A recent report by Boyle and Gardner (1) indicates that cholera toxin binds to rat thymocytes in vitro and accelerates amino acid transport via a cellular accumulation of cyclic 3',5'-adenosine monophosphate. Further studies on the role of attachment and receptor sites, as well as intracellular reactions of thymocytes treated with mycoplasmas, will indicate whether or not a similar situation exists for the membrane-associated toxin of M. fermentans.
